Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 20;42(2):232-237.
doi: 10.12122/j.issn.1673-4254.2022.02.09.

[ANA- 12 inhibits spinal inflammation and alleviates acute and chronic pain in rats by targeted blocking of BDNF/TrkB signaling]

[Article in Chinese]
Affiliations

[ANA- 12 inhibits spinal inflammation and alleviates acute and chronic pain in rats by targeted blocking of BDNF/TrkB signaling]

[Article in Chinese]
J Zhao et al. Nan Fang Yi Ke Da Xue Xue Bao. .

Abstract

Objective: To investigate the inhibitory effect of ANA-12 that blocks brain-derived neurotrophic factor (BDNF)/ tropomyosin receptor kinase B (TrkB) signaling on inflammatory pain in rats and explore the underlying mechanism.

Methods: Forty-two adult SD rats were randomized into BDNF-induced acute pain group (n=24) and CFA-induced chronic pain group. The former group were randomly divided into 4 subgroups, including a control group, ANA-12 treatment group, BDNF treatment group, and BDNF+ANA-12 treatment group; the latter group were subgrouped into control group, CFA treatment group (CFA) and CFA + ANA-12 treatment group. The effects of ANA-12 treatment on pain behaviors of the rats with BDNF-induced acute pain and CFA-induced chronic inflammatory pain were observed. Western blotting was used to examine TrkB signaling and expressions of microglia marker protein Iba1 and TNF-α in the spinal cord of the rats.

Results: BDNF injection into the subarachnoid space significantly increased the number of spontaneous paw withdrawal of the rats (P < 0.05), which was obviously reduced by ANA-12 treatment (P < 0.05). The rats with intraplantar injection of CFA, showed significantly increased ipsilateral mechanical stimulation sensitivity (P < 0.05), and ANA-12 treatment obviously increased the ipsilateral foot withdrawal threshold (P < 0.05). Treatment with either BDNF or CFA significantly increased the phosphorylation level of TrkB (Y705) in the spinal cord of the rats (P < 0.05), which was significantly lowered by ANA-12 treatment (P < 0.05). Treatment with BDNF and CFA both significantly up-regulated the expressions of Iba1 and TNF-α in the spinal cord (P < 0.05), but ANA-12 significantly reduced their expression levels (P < 0.05).

Conclusion: ANA-12 can reduce spinal cord inflammation and relieve acute and chronic pain in rats by targeted blocking of BDNF/TrkB signaling.

目的: 探讨ANA-12靶向阻断脑源性神经营养因子(BDNF)/原肌球蛋白受体激酶B(TrkB)信号对炎症痛的抑制作用及机制。

方法: 将42只大鼠随机分为7组(6只/组):BDNF处理下的对照组、ANA-12处理组、BDNF处理组以及BDNF和ANA-12联合处理组(BDNF+ANA-12);炎症痛模型下的对照组、CFA处理组以及CFA和ANA-12联合处理组(CFA+ANA-12)。给药完毕后,对各组大鼠进行痛觉行为学检测,记录ANA-12处理对BDNF-急性痛和CFA-慢性炎症痛大鼠痛觉行为的影响;采用免疫印迹法检测各组大鼠脊髓组织TrkB信号、小胶质细胞标记蛋白Iba1和促炎细胞因子TNF-α以及炎症因子IL-1β、Caspase-1、NLRP3的表达水平。

结果: 与对照组相比,BDNF增加自发缩足次数(P < 0.05);与BDNF组相比,ANA-12降低自发缩足次数(P < 0.05)。与对照组相比,CFA增加同侧机械刺激敏感性(P < 0.05);与CFA组相比,ANA-12增加同侧缩足阈值(P < 0.05)。与对照组相比,BDNF和CFA增加磷酸化TrkB(Y705)水平(P < 0.05);与BDNF或CFA组相比,ANA-12降低TrkB(Y705)磷酸化水平(P < 0.05)。与对照组相比,BDNF和CFA上调Iba1、TNF-α以及炎症因子表达(P < 0.05);与BDNF或CFA组相比,ANA-12降低Iba1、TNF-α以及炎症因子表达水平(P < 0.05)。

结论: ANA-12靶向阻断BDNF/TrkB信号可降低脊髓炎症并缓解急性痛和慢性痛。

Keywords: brain-derived neurotrophic factor; microglia; pathological pain; tropomyosin receptor kinase B; tumor necrosis factor-α.

PubMed Disclaimer

Figures

图 1
图 1
ANA-12有效缓解BDNF诱导的急性痛 ANA-12 effectively relieves BDNF-induced acute pain in rats (Mean ± SE, n=6). *P < 0.05 vs Control group; #P < 0.05 vs BDNF group.
图 2
图 2
ANA-12降低CFA诱导的炎性痛 ANA-12 reduces CFA-induced inflammatory pain in rats (Mean±SE, n=6). *P < 0.05 vs Control group; #P < 0.05 vs CFA group.
图 3
图 3
ANA-12处理阻断脊髓组织中BDNF/TrkB信号 ANA-12 treatment blocks BDNF/TrkB signaling in the spinal cord of rats (Mean ± SD, n=3). *P < 0.05 vsControl group; #P < 0.05 vs BDNF or CFA group.
图 4
图 4
ANA-12处理降低脊髓中小胶质细胞的激活和炎症信号上调 ANA-12 treatment reduces activation of microglia and up-regulation of TNF-α in the spinal cord of rats (Mean±SD, n=3). *P < 0.05 vs Control group; #P < 0.05 vs BDNF or CFA group.
图 5
图 5
炎症小体组分及炎症因子的表达 ANA-12 lowers BNDF- or CFA- induced up- regulation of inflammatory factors and components of inflammasomes in the spinal cord of the rats (Mean±SD, n=3). *P < 0.05 vs Control group; #P < 0.05 vs BDNF or CFA group.

Similar articles

Cited by

References

    1. Numakawa T, Odaka H. Brain-derived neurotrophic factor signaling in the pathophysiology of Alzheimer's disease: beneficial effects of flavonoids for neuroprotection. Int J Mol Sci. 2021;22(11):5719–27. doi: 10.3390/ijms22115719. - DOI - PMC - PubMed
    1. Lima Giacobbo B, Doorduin J, Klein HC, et al. Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation. Mol Neurobiol. 2019;56(5):3295–312. doi: 10.1007/s12035-018-1283-6. - DOI - PMC - PubMed
    1. Liu SM. Neurotrophic factors in enteric physiology and pathophysiology. Neurogastroenterol Motil. 2018;30(10):e13446-57. doi: 10.1111/nmo.13446. - DOI - PMC - PubMed
    1. Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol. 2014;220:223–50. doi: 10.1007/978-3-642-45106-5_9. - DOI - PubMed
    1. Lin YT, Ro LS, Wang HL, et al. Up-regulation of dorsal root Ganglia BDNF and trkB receptor in inflammatory pain: an in vivo and in vitro study. J Neuroinflammation. 2011;8:126–37. doi: 10.1186/1742-2094-8-126. - DOI - PMC - PubMed

Substances

Grants and funding

国家自然科学基金(81901149);湖北科技学院校级团队项目(2020TD02);湖北省教育厅项目(Q20192807)

LinkOut - more resources